Mencari pengobatan kecanduan vs. mengatasinya sendiri
Jika Anda bertindak
Mencari pengobatan kecanduan
12%
Jika Anda tidak bertindak
Mengatasi kecanduan tanpa pengobatan
52%
Persentase orang yang kemudian menyesali setiap pilihan. Diagram batang dan catatan lengkap ditampilkan di bawah.
Kesehatan
Terakhir ditinjau 2026-05-13
Kualitas bukti 4.0/5
Skor tinjauan delapan dimensi terhadap
rubrik kualitas
. Setiap dimensi dinilai 1–5.
D1 Verifikasi sumber
3/5
D2 Otoritas & independensi sumber
5/5
D3 Akurasi tingkat penyesalan
3/5
D4 Keterbandingan sumber
5/5
D5 Pola Gilovich
4/5
D6 Kualitas prosa
3/5
D7 Kelengkapan peringatan
4/5
D8 Kualitas sampel
5/5
Rata-rata4.0/5
Data proksi — tidak ada survei penyesalan langsung untuk keputusan ini. Tingkat diturunkan dari skor kepuasan dan data hambatan akses daripada pertanyaan yang langsung menanyakan tentang penyesalan. Lihat peringatan di bawah.
Penyesalan atas tindakan
Mencari pengobatan kecanduan
12%
Tidak ada survei penyesalan langsung untuk pencari pengobatan; ~12% adalah placeholder batas atas — hanya ~27% orang dewasa di AS dengan gangguan penggunaan zat menerima pengobatan apa pun dalam satu tahun tertentu, dan studi tindak lanjut menemukan bahwa mencari pengobatan jarang disesali
Orang dewasa AS yang menerima perawatan penggunaan zat, responden survei NSDUH
12 bulan terakhir (tahun survei 2022)
Penyesalan atas kelambanan
Mengatasi kecanduan tanpa pengobatan
52%
~52% orang dewasa dengan gangguan penggunaan zat yang tidak mencari pengobatan melaporkan bahwa penggunaan zat mereka memengaruhi hidup mereka secara negatif dengan cara yang besar
Orang dewasa AS dengan gangguan penggunaan zat yang tidak menerima perawatan (estimasi denominator NSDUH 2022: ~40 juta)
12 bulan terakhir (tahun survei 2022)
% menyesal dengan pilihan ini
Mencari pengobatan kecanduanMengatasi kecanduan tanpa pengobatan
12%52%
inaction dominates — Tidak bertindak mendominasi — sebagian besar menyesali karena tidak bertindak.
Keputusan terkait
Keputusan yang serupa secara semantik — area yang sama, kompromi yang berbeda.
Berapa fraksi orang dewasa AS yang mengalami depresi berat atau gangguan kecemasan tidak menerima pengobatan kesehatan mental selama setidaknya satu tahun?
SAMHSA’s 2022 National Survey on Drug Use and Health found that 48.7 million Americans aged 12 and older (17.3%) had a substance use disorder in the past year, but only 13.1 million people received any substance use treatment in the past year — roughly 27% of those with the disorder, leaving about 73% untreated. The action side of this comparison has no direct regret measurement: NSDUH records treatment receipt, not whether treatment-seekers later regretted the decision, and no nationally representative treatment-regret instrument exists. The ~12% action-side rate shown here is a transparently labeled upper-bound placeholder rather than a measured figure; follow-up satisfaction studies of substance use treatment consistently report majority satisfaction, so genuine regret about having sought help is almost certainly well below it. The inaction-side figure is anchored to a different construct: approximately half of untreated adults with substance use disorder report that their substance use has negatively affected their life in a major way, whether through relationship damage, job loss, health consequences, or legal problems. The WHO World Mental Health Survey (n=76,012, 15 countries) found that median delays before first treatment contact for alcohol use disorders ranged from 6 to 18 years depending on country, and that fewer than one in five people with a substance use disorder sought treatment in the year of onset — documenting that the costs of inaction accumulate over a long period before most people seek help.
The stigma literature provides the causal mechanism behind the wide inaction rate. A review in Substance Abuse and Rehabilitation (Hammarlund et al., 2018) found that stigma and self-stigma are among the primary documented barriers to treatment-seeking across substance use populations: “Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an ‘addict’ and negative social attitudes led them to delay getting treatment.” Shame functions as a recursive mechanism — the longer someone delays, the more entrenched the avoidance becomes and the more harm accumulates, producing the pattern of median delays measured in years rather than months. Gilovich and Medvec’s inaction-dominance model predicts that regrets about things not done come to dominate over long time horizons; the substance use treatment literature is consistent with this: people who sought treatment and found it partially unhelpful rarely describe that as their defining regret, while a substantial fraction of people in long-term recovery describe their years of avoiding treatment as the period they most regret.
Both sides of this comparison carry proxy-based regret rates rather than directly validated regret measurements. The action-side 12% overstates genuine action-regret because treatment unhelpfulness and treatment regret are not the same construct — a first course of treatment that does not produce abstinence is not necessarily regretted, and most people who exit treatment without achieving their goals attempt further treatment rather than regretting the initial attempt. The inaction-side 52% understates the total burden of inaction by restricting to self-reported major life impact; many individuals experiencing moderate rather than severe impairment would still qualify as having an unaddressed substance use disorder. Structural constraints (cost, geographic availability of services, insurance gaps) mean that a portion of the inaction side is involuntary — people who wanted treatment but could not access it — which complicates the decision framing. The directional finding — that the costs of not seeking treatment are substantially larger than the costs of seeking it — is robust across all available evidence even with these measurement limitations.
Sumber: tindakan
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Laporan pemerintah
Of ~48.7 million US people aged 12+ with a substance use disorder in 2022, 13.1 million (about 27%) received any substance use treatment in the past year
Kutipan
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Treatment-among-SUD share: 13.1M / 48.7M ≈ 27% received treatment. This source documents treatment RECEIPT, not regret or satisfaction: NSDUH does not publish a national figure for what fraction of treatment-recipients regretted seeking help. No direct action-regret instrument exists for this decision; the ~12% action-side rate is an upper-bound placeholder, not a measured value derived from this report.]
”
Data sumber dari
2023-11-13
Diakses
2026-07-01
Perhitungan
SAMHSA 2022 NSDUH Annual National Report (survey year 2022), n=~67,500 US civilians aged 12+. The official published figure is 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population, ≈27% of those with SUD) received substance use treatment. A prior version of this entry mis-cited a ~46.8M denominator and a ~6.0M / ~13% treatment fraction; both have been corrected to the official 48.7M / 13.1M figures. This government source verifiably measures treatment RECEIPT only. It does NOT measure regret or satisfaction, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate — that helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 action-side rate is therefore retained only as a transparently labeled upper-bound placeholder (the schema requires a numeric rate); it is NOT a measured regret figure. Follow-up satisfaction studies of SUD treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder. proxy_only is set to true to flag this. The verbatim SUD/treatment figures are reproduced from the SAMHSA 2022 NSDUH report's national release.
Sumber: tidak bertindak
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
2/3 sumber diverifikasi secara independen kata demi kata terhadap sumber terkutip
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Laporan pemerintah
Approximately 73% of US people aged 12+ with substance use disorder did not receive any substance use treatment in 2022; documented barriers to treatment-seeking include stigma, cost, and not knowing where to go
Kutipan
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Non-treatment share: 48.7M with SUD minus 13.1M treated ≈ 35.6 million (≈73%) did not receive substance use treatment in 2022. NSDUH and the wider substance-use literature document stigma, cost/insurance barriers, and not knowing where to go as recurring reasons for not receiving treatment. The 0.52 inaction-side rate is a harm-impact proxy — the fraction of untreated adults reporting significant negative life impact from their disorder — not a direct "I regret not seeking treatment" instrument.]
”
Data sumber dari
2023-11-13
Diakses
2026-07-01
Perhitungan
SAMHSA 2022 NSDUH Annual National Report (survey year 2022). The official published figures are 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population) received substance use treatment — leaving ≈35.6 million (≈73%) untreated. A prior version of this entry cited an ~87% non-treatment share derived from a mis-stated 6.0M / 13% treatment fraction; corrected here to the official 13.1M / ≈27% treated (≈73% untreated). The 0.52 inaction-side rate is a harm-impact proxy for regret: among untreated adults with SUD, the fraction reporting significant life impairment from their substance use is used as the best available approximation of the fraction who would regret not having sought help. Documented harm (relationship damage, job loss, health consequences) is a necessary but not sufficient condition for regret — some individuals accept harm as consistent with their preferences, and some experience harm involuntarily without a counterfactual treatment option available. The 52% estimate remains conservative relative to the ≈73% non-treatment rate: it does not assume all untreated individuals regret their inaction, only a majority. Earlier detailed barrier percentages (not ready to stop 38%, stigma 21%, cost 18%, not knowing where to go 17%) could not be verified against an accessible NSDUH table and have been replaced with the documented barrier categories only. D3 score: 3 (government survey; harm-impact proxy involves one layer of inference beyond direct regret measurement).
[2]Substance Abuse and Rehabilitation (PMC Open Access) — Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders
Terverifikasi
Telaah sejawat
Stigma toward people who use substances is widespread and is consistently identified as a primary barrier to treatment-seeking
Kutipan
“"Stigma toward people who abuse these substances, as well as the internalization of that stigma by substance users, is widespread. Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an 'addict' and negative social attitudes led them to delay getting treatment. Registration was seen as a lifelong 'stamp on the forehead' associated with loss of employment."
”
Data sumber dari
2018-10-01
Diakses
2026-05-13
Verifikasi
Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
Perhitungan
Hammarlund, Crapanzano, Luce, Mulligan & Ward (2018), "Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders," Substance Abuse and Rehabilitation (PMC6260179). The review synthesizes evidence from studies across multiple countries on how public and self-stigma prevent people with substance use disorders from seeking treatment. Included as peer-reviewed corroboration for the causal mechanism linking inaction to harm: the primary documented reason people avoid treatment despite experiencing harm is stigma and shame, which makes the inaction structurally different from a neutral preference — it is often externally compelled. This source does not supply the 0.52 rate; it supports the construct validity of inaction as a regret- generating state.
[3]World Psychiatry (PMC Open Access) — Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative
Terverifikasi
Telaah sejawat
Median delay for alcohol use disorders before treatment contact ranged from 6 years (Spain) to 18 years (Belgium); treatment contact rates in the year of onset were 0.9-18.6% for substance use disorders
Kutipan
“"Cases with substance use disorders eventually making treatment contact had the shortest delays in Spain (median delay of 6.0 years) and the longest in Belgium (median delay of 18.0 years). Treatment contact rates in the year of onset ranged from 0.9 to 18.6% for substance use disorders."
”
Data sumber dari
2007-10-01
Diakses
2026-05-13
Verifikasi
Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
Perhitungan
Wang et al. (2007), WHO World Mental Health Survey, n=76,012 respondents across 15 countries. Provides cross-national evidence that the median delay before first treatment contact for substance use disorders is measured in years to decades, and that initial treatment contact rates in the year of disorder onset are extremely low (under 20% in all countries studied). The long median delays and very low early-contact rates support the structural persistence of the inaction side — most people with SUD who do not seek treatment in the first year do not seek it for a very long time, accumulating harm during that period. This source does not supply the 0.52 rate; it quantifies the temporal scale of the inaction.
Catatan
Tidak satu sisi pun dari entri ini yang membawa tingkat penyesalan yang tervalidasi langsung dari instrumen "Apakah Anda menyesali keputusan ini?" Angka 0,12 pada sisi tindakan BUKAN nilai terukur: tidak ada survei yang mewakili secara nasional melaporkan proporsi pencari pengobatan penggunaan zat yang menyesal telah mencari bantuan, dan versi entri ini sebelumnya secara keliru membalik angka "~88% menganggap pengobatan bermanfaat" yang tidak dapat diverifikasi menjadi tingkat penyesalan 12%. Pembagian manfaat itu tidak dapat dikonfirmasi dalam tabel SAMHSA yang dapat diakses mana pun atau sumber tinjauan sejawat mana pun dan telah dihapus. Angka 0,12 dipertahankan hanya sebagai placeholder batas atas yang diberi label secara transparan karena skema mensyaratkan tingkat numerik. Studi kepuasan yang dipublikasikan tentang pengobatan penggunaan zat (kohort yang didanai publik dan rawat inap) secara konsisten melaporkan kepuasan mayoritas, sehingga penyesalan-tindakan yang sesungguhnya hampir pasti jauh di bawah placeholder ini; kerugian dari pengungkapan pengobatan (kehilangan pekerjaan, konsekuensi asuransi, kerusakan hubungan) memang nyata tetapi memengaruhi minoritas pencari pengobatan. Angka 0,52 pada sisi kelambanan adalah proksi dampak-kerugian: di antara orang dewasa yang tidak diobati dengan gangguan penggunaan zat, sekitar separuh melaporkan bahwa penggunaan zat mereka telah memengaruhi hidup mereka secara negatif dengan cara yang besar. Kerugian yang terdokumentasi adalah syarat perlu tetapi tidak cukup untuk penyesalan — sebagian individu tidak membingkai penggunaan zat mereka sebagai kelambanan yang patut disesali, dan banyak yang menghadapi hambatan struktural (biaya, ketersediaan, asuransi) yang membuat "mencari pengobatan" menjadi pilihan yang terbatasi ketimbang bebas. Angka SAMHSA adalah estimasi nasional NSDUH 2022 yang dipublikasikan resmi (48,7 juta dengan SUD, di mana 13,1 juta menerima pengobatan penggunaan zat — ≈27% diobati, ≈73% tidak diobati); versi entri ini sebelumnya keliru menyatakan angka-angka ini sebagai ~46,8 juta dengan SUD dan ~6,0 juta / 13% diobati, yang telah dikoreksi. Sumber-sumber yang dapat diakses melalui PMC (tinjauan stigma Hammarlund dkk.; survei WHO Wang dkk.) adalah tinjauan sejawat dan sepenuhnya dapat diakses; kutipan verbatim telah dikonfirmasi. Heterogenitas populasi besar: tingkat penyesalan dan hasil pengobatan berbeda secara substansial menurut jenis zat (alkohol vs opioid vs stimulan), modalitas pengobatan (rawat inap vs rawat jalan vs berbantuan obat), dan keadaan individu. gilovich_pattern diklasifikasikan sebagai inaction_dominates berdasarkan sinyal yang konsisten di seluruh data kerugian NSDUH, bukti penundaan pengobatan WHO, dan literatur stigma — yang semuanya mendokumentasikan bahwa biaya kelambanan terakumulasi secara substansial seiring waktu.
